Antibacterial activity of gatifloxacin against various fresh clinical isolates in 2002

Japanese Journal of Antibiotics

Volumn 55, Issue 6, 2002, Pages 800-807

  Matsuzaki, Kaoru ^a   Watabe, Emiko ^a   Yoshimori, Kanae ^a   Shikano, Mina ^a   Sato, Yumie ^a   Hasegawa, Miyuki ^a   Kobayashi, Intetsu ^a  

^a LSI MEDIENCE CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFDINIR; CEFIXIME; CEFODIZIME; CEFPODOXIME; CEFTRIAXONE; CEPHEM DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; NORFLOXACIN; OFLOXACIN; OXACILLIN; PENICILLIN G; QUINOLONE DERIVATIVE; SPARFLOXACIN; TOSUFLOXACIN;

ACINETOBACTER; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; DRUG POTENCY; EAR NOSE THROAT DISEASE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HUMAN; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NEISSERIA GONORRHOEAE; NONHUMAN; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; CEPHALOSPORINS; CIPROFLOXACIN; DOSAGE FORMS; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MACROLIDES; OFLOXACIN; OTORHINOLARYNGOLOGIC DISEASES; RESPIRATORY TRACT INFECTIONS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TIME FACTORS; URINARY TRACT INFECTIONS;

EID: 0036947926     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. GIAMARELLOU, H.: Activity of quinolones against gram-positive cocci: clinical features, Drugs 49 (Suppl. 2): 58-66, 1995
2. TEBAS P.; R. M. RUIZ, F. ROMAN, et al.: Early resistance to rifampin and ciprofloxacin in the treatment of right-sided Staphylococcus aureus endocarditis. J. Infect. Dis. 163: 204-205, 1991
3. FERNANDES, C. J. & V. P. ACKERMAN: In vitro studies of ciprofloxacin and survey of resistance patterns in current isolates. Diagn. Microbial. Infect. Dis. 13: 79-91, 1990
4. LOW, D. E.; J. AZAVEDO, K. WEISS, et al.: Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in Canada during 2000. Antimicrob. Agents Chemother. 46: 1295-1301, 2002
5. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard-fifth edition. NCCLS document M7-A5. Villanova, PA, 2000
6. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing; Twelfth informational supplement M100-S12. Villanova, PA, 2002
7. JORGENSEN, J. H.; L. M. WEIGEL, J. M. SWENSON, et al.: Activities of clinafloxacin, gatifloxacin, gemifloxacin and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 44: 2962-2968, 2000
8. BAUERNFEIND, A.: Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin. J. Antimicrob. Chemother. 40: 639-651, 1997
9. VALDEZATE, S.; A. VINDEL, A. ECHEITA, et al.: Topoisomerase II and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility. Antimicrob. Agents Chemother. 46: 665-671, 2002